Survey finds gaps in use of cardiovascular-kidney-metabolic syndrome tools
In a survey of health clinics participating in a new initiative to improve care for cardiovascular-kidney-metabolic (CKM) syndrome, most sites reported conducting basic screening for heart, kidney and metabolic risks. However, far fewer are using newer guideline-recommended tools such as the CKM syndrome staging framework and the American Heart Association's PREVENT (Predicting Risk of…
A new survey of health clinics implementing a cardiovascular-kidney-metabolic (CKM) syndrome initiative reveals gaps in the use of advanced screening tools. While most sites report conducting basic screenings for heart, kidney and metabolic risks, far fewer are employing newer guideline-recommended tools like the CKM syndrome staging framework and the American Heart Association's PREVENT equations.
Nearly 90% of U.S. adults have at least one component of CKM syndrome, which includes high blood pressure, abnormal cholesterol, high blood glucose, excess weight, reduced kidney function or related heart conditions. In 2025, the American Heart Association launched a learning collaborative focused on adopting a CKM-coordinated care model in about 150 clinical sites.
Of the 97 participating clinics surveyed, 75% reported screening for CKM conditions and 73% assessed CKM risk factors, but only 28% used the PREVENT equations and 22% utilized CKM staging. Lead author Dr. Chiadi Ndumele notes that these tools, while relatively new, are essential for identifying specific risks and improving care management.
The baseline findings highlight areas for targeted focus in implementation efforts to enhance CKM syndrome care.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
